Robert Kushner MD MS
Professor in Medicine, Northwestern University Medical School
Join to view full profile
680 N Lake Shore DrSte 1000Chicago, IL 60611
Phone+1 312-695-9797
Fax+1 630-926-6068
Dr. Kushner is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of ChicagoFellowship, Gastroenterology, 1982 - 1984
McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 1979 - 1981
University of Illinois College of MedicineClass of 1979
Certifications & Licensure
IL State Medical License 1980 - 2029
American Board of Internal Medicine Internal Medicine
American Board of Obesity Medicine Obesity Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification PowerChart, Cerner Corporation, 2011, 2013, 2015-2017
- CMS Meaningful Use Stage 1 Certification Northwestern Meaningful Use Data Warehouse Application for Eligible Providers, Northwestern University, 2011, 2013, 2015-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2011, 2013, 2015-2017
Publications & Presentations
PubMed
- Fixed-dose, extended-release combination of naltrexone and bupropion reduces craving and body weight: A pooled post hoc analysis.Robert F Kushner, Sylvain Iceta, Jena S Tronieri, Christopher D Still, Angela Fitch
Obesity Research & Clinical Practice. 2026-08-25 - Identifying Predictors of Weight-Related Outcomes With Fixed-Dose, Extended-Release Naltrexone and Bupropion Among Treatment-Adherent Patients in Phase 3 COR Trials: A...Donna H Ryan, Angela Fitch, Robert F Kushner, Jena S Tronieri, Christopher D Still
Obesity Science & Practice. 2026-06-01 - Use of Naltrexone-Bupropion in Persons With Overweight/Obesity and Symptoms of Depression: A Pooled Analysis.Jena Shaw Tronieri, Robert F Kushner, Caroline M Apovian, Angela Fitch, Christopher Still
Obesity. 2026-05-01
Other
- Medical management of patients after bariatric surgeryKushner RF, Cummings S
http://www.uptodate.com/contents/medical-management-of-patients-after-bariatric-surgery
UpToDate, Wolters Kluwer Health - 2012-07-05
Press Mentions
Diet and Exercise Recommendations for Patients Taking GLP-1 Receptor AgonistsMay 20th, 2026- FDA Approves Another GLP-1 Pill for Weight LossApril 3rd, 2026
- Semaglutide vs. Weight Loss Surgery: Which Is Better?October 16th, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
